ClinConnect ClinConnect Logo
Search / Trial NCT05189860

The C-MIC-II Follow-Up Study

Launched by BERLIN HEALS GMBH · Jan 12, 2022

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

ClinConnect Summary

The C-MIC-II Follow-Up Study is looking at the effects of a special medical device called the C-MIC System, which is designed to help treat heart failure by sending a small electrical current to the heart. This study is specifically for patients who have already received this device in a previous trial and aims to gather more information about how well it works over time.

To join the study, participants need to be between the ages of 65 and 74 and must have given written consent to take part. It's important to note that those who are not able or willing to attend the study visits will not be eligible. If you take part, you can expect to attend regular visits where the researchers will monitor your health and gather feedback about your experience with the device. This study is currently recruiting participants of all genders, and it provides a chance to contribute to our understanding of treatments for heart failure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who have received a C-MIC System during the C-MIC-II Study.
  • Informed consent in writing from the patient.
  • Exclusion Criteria:
  • Patients who are unwilling or unable to participate in the study visits.
  • Vulnerable Patients.

About Berlin Heals Gmbh

Berlin Heals GmbH is a forward-thinking clinical trial sponsor based in Berlin, Germany, dedicated to advancing medical research and innovation. With a focus on developing innovative therapies across various therapeutic areas, the company collaborates with leading research institutions and healthcare professionals to facilitate robust clinical trials. Berlin Heals GmbH is committed to upholding the highest ethical standards and regulatory compliance, ensuring the safety and well-being of participants while striving to bring groundbreaking treatments to market. Through its expertise in trial design and execution, the company aims to contribute significantly to the improvement of patient outcomes and the advancement of healthcare solutions.

Locations

Belgrade, Serbia

Belgrade, Serbia

Zagreb, Croatia

Sarajevo, Bosnia And Herzegovina

Banja Luka, Bosnia And Herzegovina

Skopje, North Macedonia

Patients applied

0 patients applied

Trial Officials

Peter Goettel, MD

Study Chair

Berlin Heals GmbH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials